1. Uncategorized

Autoinjectors Market worth $104.9 billion by 2025:  Availability of Generic Versions of Autoinjectors

The report “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular Diseases, Diabetes), Type (Disposable, Reusable), Route of administration (Subcutaneous, Intramuscular), End User (Hospital) – Global Forecast to 2025″ The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025.

An autoinjector is a medical device that is designed to administer medication without the need for a professional or trained individual. It is a single-use device that is pre-filled with the medication that needs to be injected. The user simply needs to place the device against their skin and press a button to deliver the medication.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724

The growth of this market is attributed to the continuous technological advancements in autoinjectors and the rising prevalence of chronic diseases. Autoinjectors are needle-free devices used for delivering injectable drugs, such as insulin, cancer therapies, and other biologics, into the body. They offer convenience and accuracy in drug delivery, and their usage is increasing in the self-administration of drugs.

As the demand for autoinjectors grows, market segmentation is becoming increasingly important for manufacturers of these medical devices. Here we discuss the various elements of autoinjector market segmentation and the potential benefits it can bring.

First, segmentation of the autoinjector market should consider technology. Autoinjectors come in a variety of types, including manual, electronic, and spring-loaded designs. Each type offers its own advantages, and understanding the differences between them can help manufacturers target their products more effectively.

Next, segmentation should also consider the end user. Autoinjectors are used to administer a variety of medications and treatments, and understanding which treatments are most popular in a given region or demographic can help manufacturers tailor their products accordingly.

Finally, segmentation should also consider the size and shape of the autoinjector. Different autoinjectors come in various sizes and shapes, and understanding which designs are most popular in a given market can help manufacturers determine which design features to prioritize.

By segmenting the autoinjector market, manufacturers can target their products more effectively, saving time and money while improving the customer experience. Segmentation also helps manufacturers stay ahead of trends and anticipate changes in consumer preferences. With the right market segmentation strategy, manufacturers can ensure their products remain competitive and remain a top choice for consumers.

Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173991724

Recent Developments

  • Antares Pharma (US) signed an agreement with Lunatus Global Medical Supplies (Dubai). In this agreement, Antares will supply packaged products to Lunatus and Lunatus will submit and obtain regulatory approval for XYOSTED in the UAE and Saudi Arabia as well as promote, market, and distribute XYOSTED in these two countries.
  • SHL Medical (Switzerland) acquired Weibel CDS (Switzerland). This acquisition aimed at strengthening SHL Medical’s ability to provide more advanced drug delivery systems based on human-centered designs and functionality.
  • Eli Lilly invested USD 470 million and created over 460 new jobs in Durham, NC. This expansion brought a new state-of-the-art pharmaceutical manufacturing facility to North Carolina’s research triangle park.
  • Becton, Dickinson and Company (US) launched a disposable autoinjector namely BD Intevia 1ml Disposable Autoinjector. This activity will strengthen company’s autoinjector’s portfolio.

Frequently Asked Questions

  • What is the current size of autoinjectors market?
  • What will be the CAGR of global autoinjectors market?
  • Who are the prominent players operating in the autoinjectors market?
  • Which are the driving factors of the autoinjectors market?
  • Which region will lead the global autoinjectors market?

Get Special Pricing on Bundle Reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=173991724

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

[email protected]

Comments to: Autoinjectors Market worth $104.9 billion by 2025:  Availability of Generic Versions of Autoinjectors